These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 4606052

  • 1. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L, Boeri S, Ricci G.
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract] [Full Text] [Related]

  • 2. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 3. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 4. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M, Riboli E, Lombardi M.
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract] [Full Text] [Related]

  • 6. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA, Caputo G.
    Clin Ter; 1976 Dec 31; 79(6):571-81. PubMed ID: 1009761
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 31; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 8. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D, Ferretti PG, Daccò L, Mazzera F.
    G Clin Med; 1977 Nov 31; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract] [Full Text] [Related]

  • 9. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R.
    Ther Ggw; 1974 May 31; 113(5):813-24. PubMed ID: 4603893
    [No Abstract] [Full Text] [Related]

  • 10. Drug treatment of hyperlipoproteinaemia.
    Romics L.
    Ther Hung; 1983 May 31; 31(4):152-60. PubMed ID: 6400456
    [No Abstract] [Full Text] [Related]

  • 11. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
    Bouissou H, Julian M, Pieraggi MT.
    Pathol Biol (Paris); 1974 Oct 31; 22(8):713-20. PubMed ID: 4614172
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic lathyrism: inhibitory effect of pyridinol carbamate on aortic atheroma in the rat (author's transl)].
    Bouissou H, Julian M, Pieraggi MT.
    Gerontologia; 1974 Oct 31; 20(2):102-24. PubMed ID: 4435365
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G, Melina D.
    Clin Ter; 1980 Mar 15; 92(5):533-47. PubMed ID: 7449327
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacotherapy of peripheral arteriosclerosis].
    Belousov IuB, Savenkov PM, Sidel'man AA, Parfenov AS, Savenkov MP.
    Kardiologiia; 1978 Aug 15; 18(8):36-43. PubMed ID: 99596
    [Abstract] [Full Text] [Related]

  • 15. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K, Witanowska A.
    Pol Tyg Lek; 1978 Aug 15; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract] [Full Text] [Related]

  • 16. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
    Dautova GS, Kosykh VA, Repin VS, Kamburg RA, Ibragimov OB, Popova LG, Valeeva IKh.
    Eksp Klin Farmakol; 1995 Aug 15; 58(1):25-9. PubMed ID: 7787689
    [Abstract] [Full Text] [Related]

  • 17. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V, Lillo V.
    Clin Ter; 1975 Oct 31; 75(2):153-69. PubMed ID: 132333
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.